{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:54:35Z","timestamp":1793120075032,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013114","name":"Broad Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015338","name":"Cancer Moonshot","doi-asserted-by":"publisher","award":["HHSN261201500003I"],"award-info":[{"award-number":["HHSN261201500003I"]}],"id":[{"id":"10.13039\/100015338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1U24-CA196173"],"award-info":[{"award-number":["1U24-CA196173"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA098413"],"award-info":[{"award-number":["U10CA098413"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA098543"],"award-info":[{"award-number":["U10CA098543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180886"],"award-info":[{"award-number":["U10CA180886"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180899"],"award-info":[{"award-number":["U10CA180899"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA114766"],"award-info":[{"award-number":["U24CA114766"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick&apos;s Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","award":["AREN03B2"],"award-info":[{"award-number":["AREN03B2"]}],"id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.xcrm.2022.100644","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:30:32Z","timestamp":1653499832000},"page":"100644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Genetic changes associated with relapse in favorable histology Wilms tumor: A Children\u2019s Oncology Group AREN03B2 study"],"prefix":"10.1016","volume":"3","author":[{"given":"Samantha","family":"Gadd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Skol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Renfro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad V.","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corbin D.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine A.","family":"Hoadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Lee","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilsa C.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Aris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quy H.","family":"Phung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6853-6221","authenticated-orcid":false,"given":"Elizabeth J.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2022.100644_bib1","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1158\/1078-0432.CCR-16-0985","article-title":"Significance of TP53 mutation in Wilms tumors with diffuse anaplasia: a report from the children's Oncology group","volume":"22","author":"Ooms","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100644_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.6004\/jnccn.2021.7070","article-title":"Impact of the first generation of children's Oncology group clinical trials on clinical practice for Wilms tumor","volume":"19","author":"Dome","year":"2021","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.xcrm.2022.100644_bib3","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/pbc.23090","article-title":"Twenty-five year follow-up of childhood Wilms tumor: a report from the childhood cancer survivor study","volume":"57","author":"Termuhlen","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.xcrm.2022.100644_bib4","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1593\/neo.12714","article-title":"Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a children's Oncology group study","volume":"14","author":"Gadd","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.xcrm.2022.100644_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1096-911X(199611)27:5<429::AID-MPO7>3.0.CO;2-O","article-title":"Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis","volume":"27","author":"Grundy","year":"1996","journal-title":"Med. Pediatr. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ebiom.2016.05.029","article-title":"Intra-tumor genetic heterogeneity in Wilms tumor: clonal evolution and clinical implications","volume":"9","author":"Cresswell","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2022.100644_bib7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/ng0293-127","article-title":"Genetic mosaicism in normal tissues of Wilms' tumour patients","volume":"3","author":"Chao","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neo.2015.12.001","article-title":"Nephron progenitor but not stromal progenitor cells give rise to Wilms tumors in mouse models with \u03b2-Catenin activation or Wt1 ablation and Igf2 upregulation","volume":"18","author":"Huang","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.xcrm.2022.100644_bib9","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1038\/ncomms5039","article-title":"Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour","volume":"5","author":"Torrezan","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100644_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ccell.2015.01.002","article-title":"Mutations in the SIX1\/2 pathway and the DROSHA\/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors","volume":"27","author":"Wegert","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100644_bib11","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/ncomms5802","article-title":"Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours","volume":"5","author":"Rakheja","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100644_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ccell.2015.02.008","article-title":"Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors","volume":"27","author":"Walz","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2022.100644_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ng.3940","article-title":"A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor","volume":"49","author":"Gadd","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/s41417-020-00268-3","article-title":"Analysis of the mutational status of SIX1\/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse","volume":"28","author":"Ciceri","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.xcrm.2022.100644_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13039-016-0227-y","article-title":"Genomic imbalances pinpoint potential oncogenes and tumor suppressors in Wilms tumors","volume":"9","author":"Krepischi","year":"2016","journal-title":"Mol. Cytogenet."},{"key":"10.1016\/j.xcrm.2022.100644_bib16","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1158\/1078-0432.CCR-09-2890","article-title":"Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor","volume":"16","author":"Williams","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100644_bib17","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.18.01972","article-title":"Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology Wilms tumor: a Children\u2019s Oncology group AREN0532 and AREN0533 study report","volume":"37","author":"Dix","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib18","first-page":"2331","article-title":"Loss of heterozygosity for chromosomes 16q and 1p in Wilms\u2019 tumors predicts an adverse outcome","volume":"54","author":"Grundy","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100644_bib19","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1200\/JCO.2005.01.2799","article-title":"Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group","volume":"23","author":"Grundy","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0002-9440(10)63982-X","article-title":"Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors","volume":"158","author":"Hing","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2022.100644_bib21","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/cncr.28239","article-title":"Gain of 1q is associated with inferior event-free and overall survival in patients with favorable histology Wilms tumor: a report from the Children's Oncology Group","volume":"119","author":"Gratias","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2022.100644_bib22","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1200\/JCO.2015.66.1140","article-title":"Association of chromosome 1q gain with inferior survival in favorable-histology Wilms tumor: a report from the Children\u2019s Oncology group","volume":"34","author":"Gratias","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib23","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1200\/JCO.2015.66.0001","article-title":"Gain of 1q as a prognostic biomarker in Wilms tumors (WTs) treated with preoperative chemotherapy in the international society of paediatric Oncology (SIOP) WT 2001 trial: a SIOP renal tumours biology consortium study","volume":"34","author":"Chagtai","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib24","series-title":"GeneReviews\u00ae","first-page":"1993","article-title":"Wilms tumor predisposition","author":"Dome","year":"2003"},{"key":"10.1016\/j.xcrm.2022.100644_bib25","first-page":"JCO2102510","article-title":"Prevalence of (Epi)genetic predisposing factors in a 5-year unselected national Wilms tumor cohort: a comprehensive clinical and genomic characterization","author":"Hol","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib26","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1242\/dev.127175","article-title":"Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators","volume":"143","author":"O'Brien","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.xcrm.2022.100644_bib27","doi-asserted-by":"crossref","first-page":"8908","DOI":"10.18632\/oncotarget.6950","article-title":"Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences","volume":"7","author":"Spreafico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2022.100644_bib28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1083\/jcb.107.4.1325","article-title":"N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in\u00a0situ hybridization","volume":"107","author":"Mugrauer","year":"1988","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.xcrm.2022.100644_bib29","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ceb.2009.09.006","article-title":"Myc's other life: stem cells and beyond","volume":"21","author":"Laurenti","year":"2009","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.xcrm.2022.100644_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.devcel.2014.10.015","article-title":"Eya1 interacts with Six2 and Myc to regulate expansion of the nephron progenitor pool during nephrogenesis","volume":"31","author":"Xu","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2022.100644_bib31","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.18632\/oncotarget.3377","article-title":"Multiple mechanisms of MYCN dysregulation in Wilms tumour","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2022.100644_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12935-021-02259-2","article-title":"MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates","volume":"21","author":"Jim\u00e9nez Mart\u00edn","year":"2021","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.xcrm.2022.100644_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Ann. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.xcrm.2022.100644_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front. Med."},{"key":"10.1016\/j.xcrm.2022.100644_bib35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","article-title":"Pan-cancer alterations of the MYC oncogene and its proximal network across the cancer genome atlas","volume":"6","author":"Schaub","year":"2018","journal-title":"Cell Syst"},{"key":"10.1016\/j.xcrm.2022.100644_bib36","doi-asserted-by":"crossref","first-page":"dju113","DOI":"10.1093\/jnci\/dju113","article-title":"Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression","volume":"106","author":"Liu","year":"2014","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.xcrm.2022.100644_bib37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/jb\/mvq004","article-title":"FOXK2 transcription factor is a novel G\/T-mismatch DNA binding protein","volume":"147","author":"Fujii","year":"2010","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.xcrm.2022.100644_bib38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-019-0900-5","article-title":"FOXK1 and FOXK2 regulate aerobic glycolysis","volume":"566","author":"Sukonina","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100644_bib39","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-017-01173-4","article-title":"YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer","volume":"8","author":"Mi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100644_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejmg.2013.10.004","article-title":"Involvement of germline DDX1-MYCN duplication in inherited nephroblastoma","volume":"56","author":"Fievet","year":"2013","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1242\/dev.117580","article-title":"LIN28: roles and regulation in development and beyond","volume":"142","author":"Tsialikas","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.xcrm.2022.100644_bib42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1101\/gad.237149.113","article-title":"Lin28 sustains early renal progenitors and induces Wilms tumor","volume":"28","author":"Urbach","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2022.100644_bib43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib44","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature12119","article-title":"A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway","volume":"497","author":"Chang","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100644_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/ng.1071","article-title":"Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility","volume":"44","author":"Astuti","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100644_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bjh.13256","article-title":"The molecular spectrum and clinical impact of DIS3 mutations in multiple myeloma","volume":"169","author":"Wei\u00dfbach","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.xcrm.2022.100644_bib48","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1038\/s41375-019-0452-6","article-title":"Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma","volume":"33","author":"Pertesi","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2022.100644_bib49","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/15476286.2015.1040978","article-title":"The 3'-5' exoribonuclease Dis3 regulates the expression of specific microRNAs in Drosophila wing imaginal discs","volume":"12","author":"Towler","year":"2015","journal-title":"RNA Biol."},{"key":"10.1016\/j.xcrm.2022.100644_bib50","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.3390\/ijms20235836","article-title":"Telomere maintenance in pediatric cancer","volume":"20","author":"Ackermann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2022.100644_bib51","first-page":"4301","article-title":"High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor","volume":"59","author":"Dome","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2022.100644_bib52","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1200\/JCO.2005.00.562","article-title":"High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor","volume":"23","author":"Dome","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib53","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1038\/ncomms8207","article-title":"TCF12 is mutated in anaplastic oligodendroglioma","volume":"6","author":"Labreche","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2022.100644_bib54","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/hmg\/ddv083","article-title":"HCFC1 loss-of-function mutations disrupt neuronal and neural progenitor cells of the developing brain","volume":"24","author":"Jolly","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib55","doi-asserted-by":"crossref","first-page":"19265","DOI":"10.1074\/jbc.M808740200","article-title":"Retinoblastoma\/p107\/p130 pocket proteins","volume":"284","author":"Stengel","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2022.100644_bib56","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1200\/EDBK_280749","article-title":"Chasing ctDNA in patients with sarcoma","volume":"40","author":"Coombs","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.xcrm.2022.100644_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27595","article-title":"Assessment of circulating tumor DNA in pediatric solid tumors: the promise of liquid biopsies","volume":"66","author":"Abbou","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.xcrm.2022.100644_bib58","article-title":"Circulating tumor DNA as a biomarker in favourable histology Wilms Tumor (WT) patients","author":"Madanat-Harjuoja","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2022.100644_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature17676","article-title":"Landscape of somatic mutations in 560 breast cancer whole-genome sequences","volume":"534","author":"Nik-Zainal","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100644_bib60","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1093\/bioinformatics\/btp394","article-title":"Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads","volume":"25","author":"Ye","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib61","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.128","article-title":"Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing","volume":"40","author":"Campbell","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2022.100644_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cpbi.17","article-title":"ascatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data","volume":"56","author":"Raine","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/bioinformatics\/btv642","article-title":"Two-pass alignment improves novel splice junction quantification","volume":"32","author":"Veeneman","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib66","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkv808","article-title":"Large-scale profiling of microRNAs for the cancer genome atlas","volume":"44","author":"Chu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2022.100644_bib67","series-title":"Genomics in the Cloud: Using Docker, GATK, and WDL in Terra","author":"Van der Auwera","year":"2020"},{"key":"10.1016\/j.xcrm.2022.100644_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl variant Effect predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2022.100644_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.xcrm.2022.100644_bib70","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13104-019-4343-8","article-title":"Human protein-coding genes and gene feature statistics in 2019","volume":"12","author":"Piovesan","year":"2019","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.xcrm.2022.100644_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"Gigascience"},{"key":"10.1016\/j.xcrm.2022.100644_bib72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data: figure 1","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2022.100644_bib73","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"key":"10.1016\/j.xcrm.2022.100644_bib74","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.xcrm.2022.100644_bib75","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2022.100644_bib76","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics knowledge for personalized medicine","volume":"92","author":"Whirl-Carrillo","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2022.100644_bib77","first-page":"611","article-title":"PGxMine: text mining for curation of PharmGKB","volume":"25","author":"Lever","year":"2020","journal-title":"Pac. Symp. Biocomput."},{"key":"10.1016\/j.xcrm.2022.100644_bib78","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/bioinformatics\/btx075","article-title":"LASER server: ancestry tracing with genotypes or sequence reads","volume":"33","author":"Taliun","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2022.100644_bib79","unstructured":"Wickham H. ggplot2: Elegant Graphics for Data Analysis. In Springer-Verlag New York. ISBN 978-3-319-24277-4, 2016"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379122001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:50:30Z","timestamp":1762987830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379122001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2666379122001690"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100644","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic changes associated with relapse in favorable histology Wilms tumor: A Children\u2019s Oncology Group AREN03B2 study","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2022.100644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"100644"}}